EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress

EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress

Abstract Background Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer that lacks expression of estrogen receptor (ER) and progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2) gene. Chemotherapy remains the standard of care for TNBC tre...

Full description

Bibliographic Details
Main Authors: Ruishan Zhang, Xiang Li, Zhuangkai Liu, Yuying Wang, Hao Zhang, Hong Xu
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Cancer Cell International
Subjects:
TNBC
EZH2
FOSB
C/EBPβ
Epigenetic inactivation
Online Access:http://link.springer.com/article/10.1186/s12935-020-01260-5

Internet

http://link.springer.com/article/10.1186/s12935-020-01260-5

Similar Items